Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Users | 3 | 2022 | 20 | 1.190 |
Why?
|
| Hepatitis C | 3 | 2022 | 219 | 0.980 |
Why?
|
| Colorectal Neoplasms | 3 | 2024 | 966 | 0.730 |
Why?
|
| Computer Simulation | 4 | 2024 | 1095 | 0.710 |
Why?
|
| Adenoma | 1 | 2022 | 242 | 0.700 |
Why?
|
| HIV Infections | 6 | 2022 | 825 | 0.540 |
Why?
|
| Models, Theoretical | 3 | 2022 | 489 | 0.440 |
Why?
|
| Colonoscopy | 2 | 2022 | 273 | 0.350 |
Why?
|
| Pre-Exposure Prophylaxis | 3 | 2021 | 143 | 0.340 |
Why?
|
| Chicago | 6 | 2022 | 1407 | 0.320 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 409 | 0.320 |
Why?
|
| Referral and Consultation | 2 | 2021 | 341 | 0.300 |
Why?
|
| Neoplasms | 2 | 2018 | 2995 | 0.280 |
Why?
|
| Population Growth | 1 | 2005 | 11 | 0.270 |
Why?
|
| Fractals | 1 | 2005 | 42 | 0.260 |
Why?
|
| Emigration and Immigration | 1 | 2005 | 49 | 0.260 |
Why?
|
| Bayes Theorem | 2 | 2024 | 366 | 0.260 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2024 | 59 | 0.260 |
Why?
|
| Incidence | 4 | 2022 | 1588 | 0.240 |
Why?
|
| Opiate Substitution Treatment | 1 | 2024 | 38 | 0.240 |
Why?
|
| Methadone | 1 | 2024 | 44 | 0.240 |
Why?
|
| Reproduction | 1 | 2005 | 197 | 0.240 |
Why?
|
| Risk-Taking | 2 | 2022 | 155 | 0.230 |
Why?
|
| Homosexuality, Male | 3 | 2022 | 298 | 0.220 |
Why?
|
| Hepatitis B | 1 | 2023 | 76 | 0.220 |
Why?
|
| Policy | 1 | 2022 | 35 | 0.200 |
Why?
|
| Sexual and Gender Minorities | 2 | 2022 | 200 | 0.200 |
Why?
|
| Humans | 22 | 2024 | 88354 | 0.200 |
Why?
|
| Virus Replication | 1 | 2023 | 322 | 0.200 |
Why?
|
| Health Information Exchange | 1 | 2021 | 12 | 0.200 |
Why?
|
| Hand Disinfection | 1 | 2021 | 17 | 0.200 |
Why?
|
| Systems Analysis | 1 | 2021 | 17 | 0.200 |
Why?
|
| Hepacivirus | 2 | 2022 | 165 | 0.200 |
Why?
|
| Viremia | 1 | 2021 | 56 | 0.200 |
Why?
|
| Workflow | 2 | 2018 | 78 | 0.200 |
Why?
|
| Community Networks | 1 | 2021 | 29 | 0.200 |
Why?
|
| Masks | 1 | 2021 | 29 | 0.200 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 178 | 0.200 |
Why?
|
| Social Class | 1 | 2022 | 134 | 0.190 |
Why?
|
| Young Adult | 6 | 2022 | 6179 | 0.190 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 127 | 0.190 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 414 | 0.180 |
Why?
|
| Crime | 1 | 2020 | 36 | 0.180 |
Why?
|
| Adolescent | 6 | 2022 | 9131 | 0.180 |
Why?
|
| Criminals | 1 | 2020 | 33 | 0.180 |
Why?
|
| Viral Hepatitis Vaccines | 1 | 2019 | 5 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 1 | 2019 | 58 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2020 | 194 | 0.160 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 154 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2020 | 99 | 0.160 |
Why?
|
| Models, Biological | 1 | 2005 | 1763 | 0.160 |
Why?
|
| Algorithms | 2 | 2024 | 1857 | 0.160 |
Why?
|
| Patient Compliance | 1 | 2019 | 227 | 0.150 |
Why?
|
| Smoking Cessation | 1 | 2019 | 250 | 0.140 |
Why?
|
| Adult | 8 | 2024 | 26257 | 0.140 |
Why?
|
| Machine Learning | 1 | 2018 | 241 | 0.140 |
Why?
|
| Male | 8 | 2022 | 41885 | 0.110 |
Why?
|
| Calibration | 2 | 2024 | 102 | 0.110 |
Why?
|
| Middle Aged | 4 | 2022 | 25607 | 0.090 |
Why?
|
| Illinois | 2 | 2021 | 465 | 0.080 |
Why?
|
| Pandemics | 2 | 2023 | 760 | 0.070 |
Why?
|
| Female | 4 | 2022 | 45612 | 0.070 |
Why?
|
| Needle Sharing | 1 | 2024 | 15 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2021 | 2832 | 0.060 |
Why?
|
| Monte Carlo Method | 1 | 2024 | 186 | 0.060 |
Why?
|
| Hepatitis B virus | 1 | 2023 | 44 | 0.060 |
Why?
|
| Virion | 1 | 2023 | 59 | 0.060 |
Why?
|
| Texas | 1 | 2022 | 108 | 0.050 |
Why?
|
| HIV | 1 | 2022 | 48 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2023 | 265 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 2586 | 0.050 |
Why?
|
| Infectious Disease Medicine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 50 | 0.050 |
Why?
|
| California | 1 | 2021 | 143 | 0.050 |
Why?
|
| Uncertainty | 1 | 2021 | 73 | 0.050 |
Why?
|
| San Francisco | 1 | 2020 | 23 | 0.050 |
Why?
|
| Computational Biology | 1 | 2024 | 536 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2021 | 98 | 0.050 |
Why?
|
| Geography | 1 | 2021 | 228 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 356 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 371 | 0.050 |
Why?
|
| Kinetics | 1 | 2023 | 1528 | 0.050 |
Why?
|
| Public Health | 1 | 2021 | 135 | 0.050 |
Why?
|
| Health Behavior | 1 | 2021 | 183 | 0.050 |
Why?
|
| Poverty | 1 | 2021 | 179 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 185 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 435 | 0.040 |
Why?
|
| Vaccine Potency | 1 | 2019 | 1 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 18875 | 0.040 |
Why?
|
| Forecasting | 1 | 2020 | 305 | 0.040 |
Why?
|
| Internet | 1 | 2021 | 317 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 994 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 577 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 253 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 514 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1061 | 0.040 |
Why?
|
| Mass Screening | 1 | 2022 | 631 | 0.040 |
Why?
|
| Vaccination | 1 | 2019 | 267 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2019 | 233 | 0.040 |
Why?
|
| Logistic Models | 1 | 2020 | 1204 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 453 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 869 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 1687 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2019 | 340 | 0.030 |
Why?
|
| Decision Making | 1 | 2021 | 661 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2019 | 575 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1246 | 0.030 |
Why?
|
| Animals | 2 | 2023 | 27129 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6704 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 11685 | 0.020 |
Why?
|
| United States | 1 | 2021 | 6867 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8135 | 0.020 |
Why?
|